ICU Medical, Inc.
$130.58
▼
-1.53%
2026-04-21 07:27:00
www.icumed.com
NMS: ICUI
Explore ICU Medical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$3.27 B
Current Price
$130.58
52W High / Low
$160.29 / $107
Stock P/E
4,461.76
Book Value
$86.03
Dividend Yield
—
ROCE
3.08%
ROE
0.04%
Face Value
—
EPS
$0.03
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
13,000
Beta
0.85
Debt / Equity
63.48
Current Ratio
2.39
Quick Ratio
1.15
Forward P/E
13.66
Price / Sales
1.41
Enterprise Value
$4.14 B
EV / EBITDA
13.35
EV / Revenue
1.85
Rating
None
Target Price
$182.67
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
- Valuation is rich on a P/E basis.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Zentek Ltd. | $0.5 | — | $73.33 M | — | -64.39% | -56.64% | $2.5 / $0.63 | $0.08 |
| 2. | Becton, Dickinson and Company | $155.63 | 25.5 | $44.7 B | 2.65% | 6.35% | 6.96% | $187.35 / $127.54 | $88.79 |
| 3. | Sanara MedTech Inc. | $20.62 | — | $190.4 M | — | 16.84% | -1.75% | $35.95 / $16.05 | $0.66 |
| 4. | Utah Medical Products, Inc. | $70.22 | 20.02 | $225.9 M | 1.77% | 9.51% | 9.54% | $71.81 / $51.26 | $37.43 |
| 5. | KORU Medical Systems, Inc. | $4.26 | — | $200.78 M | — | -14.86% | -15.58% | $6.61 / $2.08 | $0.37 |
| 6. | AtriCure, Inc. | $28.79 | — | $1.51 B | — | -1.65% | -2.4% | $43.18 / $27.26 | $9.88 |
| 7. | Pulse Biosciences, Inc. | $23.73 | — | $1.61 B | — | -88.83% | -74.45% | $26.3 / $12.56 | $1.19 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 540.7 M | 536.99 M | 548.87 M | 604.7 M | 629.8 M | — |
| Operating Profit | 26.09 M | 26.86 M | 26.8 M | 29.59 M | 46.05 M | — |
| Net Profit | -15.73 M | -3.4 M | 35.34 M | -15.48 M | -23.83 M | — |
| EPS in Rs | -0.63 | -0.14 | 1.41 | -0.62 | -0.95 | -1.35 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 2.23 B | 2.38 B | 2.26 B | 2.28 B |
| Operating Profit | 109.33 M | 97.41 M | 47.84 M | -3.57 M |
| Net Profit | 0.73 M | -117.69 M | -29.66 M | -74.29 M |
| EPS in Rs | 0.03 | -4.71 | -1.19 | -2.97 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 4.05 B | 4.2 B | 4.38 B | 4.52 B |
| Total Liabilities | 1.93 B | 2.24 B | 2.26 B | 2.43 B |
| Equity | 2.12 B | 1.97 B | 2.12 B | 2.09 B |
| Current Assets | 1.19 B | 1.44 B | 1.22 B | 1.24 B |
| Current Liabilities | 498.86 M | 556.18 M | 481.84 M | 494.56 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 179.85 M | 204.03 M | 166.2 M | -62.13 M |
| Investing CF | 122.23 M | -88.96 M | -87.95 M | -1.91 B |
| Financing CF | -311.52 M | -55.8 M | -35.98 M | 1.64 B |
| Free CF | 82.83 M | 113.83 M | 72.53 M | -161.46 M |
| Capex | -97.02 M | -90.21 M | -93.67 M | -99.33 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 5.44% | -0.92% | — | — |
| Earnings Growth % | -296.86% | 60.08% | — | — |
| Profit Margin % | -4.94% | -1.31% | -3.26% | — |
| Operating Margin % | 4.09% | 2.12% | -0.16% | — |
| Gross Margin % | 34.62% | 32.75% | 30.6% | — |
| EBITDA Margin % | 10.92% | 11.21% | 8.4% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.